Riskpilot← Back to searchSign inGet full accessGoran Simins psykiatrisk Konsult AB
ABActiveOrg 5567310221Medical specialists activities · NACE 8622Est. 20072 employees
Revenue 2024
SEK 1,8M
-8% vs 2023
EBITDA margin
12.4%
+25% vs 2023
Equity ratio
95.9%
Financial strength
Net profit 2024
SEK 205K
+28% vs 2023
| Revenue | SEK 1,8M | -8% |
| EBITDA | SEK 229K | +25% |
| Net profit | SEK 205K | +28% |
| Total assets | SEK 668K | +5% |
| Equity | SEK 641K | +47% |
| Employees | 2 | — |
Legal name
Goran Simins psykiatrisk Konsult AB
Org number
5567310221
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
1 juni 2007
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är konsultverksamhet inom psykiatriska vården och därmed förenlig verksamhet.
Address
Phone
+46854475300
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 134 | 2 144 | 2 006 | 2 004 | 1 840 |
| Staff expenses | — | — | −1 900 | −1 501 | −1 304 |
| EBITDA | 227 | −159 | −216 | 183 | 229 |
| Depreciation & amort. | −1 | −21 | −21 | −21 | −21 |
| EBIT | 226 | −180 | −238 | 162 | 207 |
| Net financials | −1 | — | −2 | −2 | −2 |
| Profit before tax | 225 | −181 | −239 | 160 | 205 |
| Tax | −12 | −0 | — | — | — |
| Net profit | 213 | −181 | −239 | 160 | 205 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 861 | 699 | 484 | 634 | 668 |
| Equity | 644 | 514 | 275 | 435 | 641 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 217 | 184 | 210 | 198 | 27 |
| Total debt | 217 | 184 | 210 | 198 | 27 |
EBITDA margin
12.4%
This company
15.8%
Market median
-22% vs market
20202024
Equity ratio
95.9%
This company
38.2%
Market median
+151% vs market
20202024
Return on equity
32.0%
This company
18.4%
Market median
+74% vs market
20202024
Net profit margin
11.2%
This company
8.1%
Market median
+38% vs market
20202024
Asset turnover
2.76×
This company
1.12×
Market median
+146% vs market
20202024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GK Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Goran Simins psykiatrisk Konsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Goran Kareem Simin | Chief Executive Officer | 0 companies |
| Johanna Simin | Deputy Board Member | 0 companies |